Clinical trials

Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of t3 and t4a (and Selected t4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (Npnscc) (ea3163)

Evaluation of a Biomarker Test for the Early Molecular Profiling of Lung Cancer Utilizing Cytological Samples (ATLAS DHF 011-003P)

Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy

A Phase II Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma (PCG PAN009-18)

Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI) Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction

A Phase II trial of SMO/AKT/NF2/CDK inhibitors in progressive meningiomas with SMO/AKT/NF2/CDK pathway mutations (A071401)

The Pancreatic Early Detection Consortium (PRECEDE)

Redefining The Use Of a FOLFIRINOX-Like Regimen In the Front Line In Older Patients With Metastatic Pancreatic Cancer (GI 170)

A Phase I/Ib Trial of the CDK4/6 Antagonist Ribociclib And The HDAC Inhibitor Belinostat In Patients With Metastatic Triple Negative Breast Cancer And Recurrent Ovarian Cancer With Response Prediction By Genomics (CHARGE)

Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts